
Waardenburg Wisdom: Navigating Genetic Testing for Waardenburg Syndrome Type 2A
Sensorineural hearing loss present at birth, plus patchy depigmentation of skin, hair and eyes, marks type 2A; MITF testing confirms it and clarifies family risk.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Sensorineural hearing loss present at birth, plus patchy depigmentation of skin, hair and eyes, marks type 2A; MITF testing confirms it and clarifies family risk.

Early separation of chromatids destabilizes chromosomes and is linked to reproductive difficulty and higher cancer risk; testing confirms the trait in a family.

When a fertility work-up finds no clear cause, chromosome analysis may show sister chromatids parting at metaphase, pointing to PCS as the underlying reason.

There is no cure for the trait, so testing is used to explain otherwise unexplained male infertility, shape fertility care and describe the risk to relatives.

Karyotyping, which examines the number and structure of chromosomes, is how the trait is usually spotted, and results guide counseling on passing it to children.

Because the trait can run in families, couples are offered preimplantation genetic diagnosis or IVF with donor gametes once early chromatid separation is found.

Standard diagnostic methods often miss the subtle chromosomal changes involved, so specific genetic markers are used; a male infertility case shows the process.

Cells that divide with chromatids already separated can lead to infertility, developmental delays and raised cancer risk, so a confirmed result brings monitoring.